One Nucleus: Adopting Strategies that Successfully Impact Drug Development Programs Including Rare Diseases

  • Thursday, 13 October 2022, 11:00 AM to 1:00 PM

This lunch and learn session, facilitated by Zizi Imatorbhebhe, Senior Vice President, Global Strategy & Development, Rare Disease, Head Rare Disease Innovation Center at Ergomed, will cover: 

  • The big challenges facing Drug Development including Rare Diseases 
  • What the small biotechnology companies need to keep in mind when embarking on a drug development program
  • How to leverage Ergomed's Rare Disease innovation center to accelerate your drug development program

 This event is free to attend.

Find out more from One Nucleus

Stevenage Bioscience Catalyst is the UK's leading open innovation campus with a focus on therapeutics.

Learn more

We use cookies to improve our site experience. Press accept to agree to our Cookie Policy. If you decline, your information won’t be tracked when you visit this website. A single cookie will be used in your browser to remember your preference not to be tracked.